UBS Maintains a 'Neutral' on Itron (ITRI); Updating Outlook
Tweet
Share
E-mailGet Alerts ITRI Hot Sheet
Price: $101.56 -1.13%
Rating Summary:
16 Buy, 16 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
16 Buy, 16 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on Itron (NASDAQ: ITRI) price target raised from $39 to $46.
UBS analyst says, "We are reducing our ’12E EPS to $4.20 (was $4.25) to reflect SmartSynch dilution (guidance <10c dilution). While we see some risk to our ‘13/’14 estimates, ITRI seemed incrementally confident that European smart meter demand will pick up in ’13 and beyond, and even commented that it was concerned about its production capacity for potential 2015 demand levels. However, we continue to have some concerns about the potential profitability of the large European smart meter contracts." (UBS lowers FY13 EPS estimate from $4.65 to $4.40)
For an analyst ratings summary and ratings history on Itron click here. For more ratings news on Itron click here.
Shares of Itron closed at $44.68 yesterday.
UBS analyst says, "We are reducing our ’12E EPS to $4.20 (was $4.25) to reflect SmartSynch dilution (guidance <10c dilution). While we see some risk to our ‘13/’14 estimates, ITRI seemed incrementally confident that European smart meter demand will pick up in ’13 and beyond, and even commented that it was concerned about its production capacity for potential 2015 demand levels. However, we continue to have some concerns about the potential profitability of the large European smart meter contracts." (UBS lowers FY13 EPS estimate from $4.65 to $4.40)
For an analyst ratings summary and ratings history on Itron click here. For more ratings news on Itron click here.
Shares of Itron closed at $44.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)
- Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy
- RWE (RWE:GR) (RWNFF) PT Raised to EUR66 at RBC Capital
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
